tirzepatide for heart failure with preserved ejection fraction and obesity American Association Scientific Sessions 2024 has started off a bang! Results are in the SUMMIT study: Treatment with (Mounjaro/ Zepbound) was associated with 38% ⬇️ in combined risk Effects of Tirzepatide on the

"It also points to the need for better strategies to make these treatments more accessible and available to those who need them.However, researchers noted that larger studies involving more women are needed to confirm their findings and figure out why hormone therapy might boost GLP-1 drug effectiveness.Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.More information The Mayo Clinic has more on menopause hormone therapy.SOURCE: The Endocrine Society, news release, July 12, 2025 .What This Means For YouWomen should talk to their doctor about using menopause hormone therapy and GLP-1 drugs..Sign up for our weekly HealthDay newsletter

Mitochondrial DNA polymerase-gamma and human disease

Follow with an IPL/1540 combo for brighter, renewed skin

The regenerative and protective actions of GHK-Cu make it a key player in maintaining overall cellular health

Algunos han reportado cambios positivos al integrarlo a sus programas regulares